Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

VCL inhibits KCNMA1. 2 / 2

| 2

➶

reach

"We thus expect that the use of a -100 mV holding potential during voltage clamp recordings will reduce [Ca] i and the available KCa1.1 current."

23626738

➶

reach

"Neutralization of the last lysine residue (K304) in this cluster also reduced gamma3 's modulatory effect on the BK channel V 1/2 by nearly 30 mV (V 1/2 = 144 +/- 2 mV with gamma3 K304N mutant vs. 115 +/- 2 mV with wild type) (XREF_FIG)."

26009545

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...